Online intervention for sexual health concerns in gynecologic cancer survivors
eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
This study is testing an online program to help gynecologic cancer survivors deal with sexual health concerns by trying different types of therapy to see which works best for them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 19 Years and up |
| Sex | Female |
| Sponsor | University of British Columbia Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Vancouver, British Columbia) |
| Trial ID | NCT06619769 on ClinicalTrials.gov |
What this trial studies
This research evaluates an adapted online intervention aimed at addressing sexual health issues faced by gynecologic cancer survivors. Participants will complete baseline questionnaires and undergo a 4-week waiting period before being randomized into one of four groups receiving either cognitive-behavioral therapy (CBT) or mindfulness-based therapy (MBT), with or without navigator support. The intervention involves weekly or biweekly modules over 8-16 weeks, with assessments of usability and outcomes related to sexual distress and function. The goal is to enhance access to sexual health resources for survivors, particularly those facing barriers to care.
Who should consider this trial
Good fit: Ideal candidates include individuals with a history of gynecologic cancer who experience sexual difficulties and have reliable internet access.
Not a fit: Patients currently undergoing active cancer treatment or those with unmanaged anxiety or mood disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve sexual health and quality of life for gynecologic cancer survivors.
How similar studies have performed: Other studies have shown promise in using online interventions for sexual health concerns, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-report a current or history of gynecologic cancer of any subtype * self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised * are fluent in English (eSense content is delivered in English) * have reliable internet access and basic competency in using online platforms (individuals will self-report) * are available for 8 - 16 weeks and able to complete eSense modules and associated questionnaires * any gender Exclusion Criteria: * have visual impairments or disabilities interfering with reading and ability to interact with online materials * have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening) * individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).
Where this trial is running
Vancouver, British Columbia
- University of British Columbia — Vancouver, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: Lori A Brotto, PhD, RPsych — University of British Columbia
- Study coordinator: Nisha Marshall, MSc
- Email: nisha.marshall@cw.bc.ca
- Phone: 6048754111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.